Fig. 7.

The risk score of hypoxia-related lncRNA was associated with immunotherapy, microsatellite instability and tumor mutation burden in EC. a–d The response to anti-CTLA-4 and anti-PD-1 treatment between different risk score group. e, f The relationship between hypoxia-related lncRNA risk score and microsatellite instability in EC patients. g The tumor mutation burden levels in different risk score group. h The Pearson correlation coefficients between tumor mutation burden levels and risk scores. i, j Kaplan–Meier analysis showed the correlation between tumor mutation burden and EC prognosis (i), and the difference in survival rate according to risk score between different TMB subgroups (j)